Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aconitum gymnandrum is a plant species within the Ranunculaceae family, specifically the monotypic subgenus Gymnaconitum. It is a significant ingredient in traditional Chinese medicine (TCM), valued for its analgesic, anti-inflammatory, and anti-tumor properties. The plant's therapeutic and toxic effects are primarily attributed to its diterpenoid alkaloids, such as gymnaconitines, talatizamine, condelphine, isotalatizidine, and atisine. These compounds are known to modulate voltage-gated sodium channels, which contributes to both its medicinal actions and its considerable toxicity, particularly affecting the cardiovascular and central nervous systems. Traditional processing methods are often employed to mitigate its inherent toxicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aconitum gymnandrum.